体型指数与动脉硬化关系的研究进展

doi:10.12114/j.issn.1007-9572.2023.0506

摘要/Abstract

摘要： 体型指数（ABSI）是基于身高、体质量、腰围等测量指标通过特定算法衍生的新型人体测量学指标。随着超重和肥胖人群的日益增多，腹型肥胖对于心血管事件发生和死亡的预测作用更强。肥胖通过产生炎症因子，诱发慢性炎症反应、胰岛素抵抗、代谢紊乱和氧化应激途径等导致动脉硬化、高血压、冠心病等心血管疾病的发病甚至死亡。ABSI与腹型肥胖相关性较好，在部分人群中可以预测动脉硬化，但同时也受到人群特征的影响。例如，不同地区、性别和年龄的人群中，ABSI与动脉硬化之间的相关性存在差异。明确ABSI与动脉硬化的关系，对早期发现动脉硬化的高危人群和合理防治心血管疾病有重要意义。

关键词: 动脉硬化, 体型指数, 腹型肥胖, 人体测量术, 体质指数

Abstract:

A body shape index (ABSI) is a novel anthropometric index derived by specific algorithms based on measurements of height, weight, and waist circumference. Central obesity has become more important for predicting the occurrence and mortality of cardiovascular events with the increasing number of overweight and obese people. Obesity contributes to the development of cardiovascular diseases such as atherosclerosis, hypertension, coronary heart disease and even death by stimulating the production of inflammatory factors that induce chronic inflammatory responses, insulin resistance, metabolic disorders and oxidative stress pathways. ABSI is strongly related to abdominal obesity and can predict atherosclerosis in some populations, but it is also affected by population characteristics, such as the difference in the correlation between ABSI and atherosclerosis in populations of different regions, genders and ages. It is of great significance for early identification of high-risk populations and rational prevention and treatment of cardiovascular diseases to clarify the relationship between ABSI and atherosclerosis.

Key words: Arteriosclerosis, A body shape index, Abdominal obesity, Anthropometry, Body mass index

陈小茜,李利华. 体型指数与动脉硬化关系的研究进展[J]. 中国全科医学, 2024, 27(15): 1899-1903. DOI: 10.12114/j.issn.1007-9572.2023.0506.
CHEN Xiaoqian,LI Lihua. Advancements in the Association between a Body Shape Index and Atherosclerosis[J]. Chinese General Practice, 2024, 27(15): 1899-1903. DOI: 10.12114/j.issn.1007-9572.2023.0506.

图/表 1

参考文献 45

[1]	FEDERATION W O. World Obesity Atlas 2023[EB/OL]. （2023-03-04）[2023-04-30].
[2]	WANG Y F, ZHAO L, GAO L W，et al. Health policy and public health implications of obesity in China[J]. Lancet Diabetes Endocrinol，2021，9(7):446-461. DOI：10.1016/S2213-8587(21)00118-2.
[3]	HEROUVI D, KARANASIOS E, KARAYIANNI C，et al. Cardiovascular disease in childhood: the role of obesity[J]. Eur J Pediatr，2013，172(6):721-732. DOI：10.1007/s00431-013-1932-8.
[4]	YUAN S, BRUZELIUS M, XIONG Y，et al. Overall and abdominal obesity in relation to venous thromboembolism[J]. J Thromb Haemost，2021，19(2):460-469. DOI：10.1111/jth.15168.
[5]	KRAKAUER N Y, KRAKAUER J C. A new body shape index predicts mortality hazard independently of body mass index[J]. PLoS One，2012，7(7):e39504. DOI：10.1371/journal.pone.0039504.
[6]	KRAKAUER N Y, KRAKAUER J C. Dynamic association of mortality hazard with body shape[J]. PLoS One，2014，9(2):e88793. DOI：10.1371/journal.pone.0088793.
[7]	LI G, WU H K, WU X W，et al. The feasibility of two anthropometric indices to identify metabolic syndrome，insulin resistance and inflammatory factors in obese and overweight adults[J]. Nutrition，2019，57:194-201. DOI：10.1016/j.nut.2018.05.004.
[8]	NAGAYAMA D, FUJISHIRO K, WATANABE Y，et al. A body shape index（ABSI）as a variant of conicity index not affected by the obesity paradox：a cross-sectional study using arterial stiffness parameter[J]. J Pers Med，2022，12(12):2014. DOI：10.3390/jpm12122014.
[9]	HARAGUCHI N, KOYAMA T, KURIYAMA N，et al. Assessment of anthropometric indices other than BMI to evaluate arterial stiffness[J]. Hypertens Res，2019，42(10):1599-1605. DOI：10.1038/s41440-019-0264-0.
[10]	JAYEDI A, SOLTANI S, ZARGAR M S，et al. Central fatness and risk of all cause mortality: systematic review and dose-response meta-analysis of 72 prospective cohort studies[J]. BMJ，2020，370:m3324. DOI：10.1136/bmj.m3324.
[11]	CHANG Y, GUO X F, LI T，et al. A body shape index and body roundness index: two new body indices to identify left ventricular hypertrophy among rural populations in northeast China[J]. Heart Lung Circ，2016，25(4):358-364. DOI：10.1016/j.hlc.2015.08.009.
[12]	LI P, WANG L, LIU C. Overweightness，obesity and arterial stiffness in healthy subjects: a systematic review and meta-analysis of literature studies[J]. Postgrad Med，2017，129:224-230. DOI：10.1080/00325481.2017.1268903.
[13]	KOENEN M, HILL M A, COHEN P，et al. Obesity，adipose tissue and vascular dysfunction[J]. Circ Res，2021，128(7):951-968. DOI：10.1161/CIRCRESAHA.121.318093.
[14]	COX A J, WEST N P, CRIPPS A W. Obesity，inflammation，and the gut microbiota[J]. Lancet Diabetes Endocrinol，2015，3(3):207-215. DOI：10.1016/S2213-8587(14)70134-2.
[15]	AROOR A R, JIA G H, SOWERS J R. Cellular mechanisms underlying obesity-induced arterial stiffness[J]. Am J Physiol Regul Integr Comp Physiol，2018，314(3):387-398. DOI：10.1152/ajpregu.00235.2016.
[16]	MOUTON A J, LI X, HALL M E，et al. Obesity，hypertension，and cardiac dysfunction: novel roles of immunometabolism in macrophage activation and inflammation[J]. Circ Res，2020，126(6):789-806. DOI：10.1161/CIRCRESAHA.119.312321.
[17]	DORONZO G, RUSSO I, MATTIELLO L，et al. Insulin activates vascular endothelial growth factor in vascular smooth muscle cells: influence of nitric oxide and of insulin resistance[J]. Eur J Clin Invest，2004，34(10):664-673. DOI：10.1111/j.1365-2362.2004.01412.x.
[18]	HILL M A, YANG Y, ZHANG L P，et al. Insulin resistance，cardiovascular stiffening and cardiovascular disease[J]. Metabolism，2021，199:154766. DOI：10.1016/j.metabol.2021.154766.
[19]	JIA G H, HABIBI J, BOSTICK B P，et al. Uric acid promotes left ventricular diastolic dysfunction in mice fed a Western diet[J]. Hypertension，2015，65(3):531-539. DOI：10.1161/HYPERTENSIONAHA.114.04737.
[20]	LASTRA G, MANRIQUE C, JIA G H，et al. Xanthine oxidase inhibition protects against Western diet-induced aortic stiffness and impaired vasorelaxation in female mice[J]. Am J Physiol Regul Integr Comp Physiol，2017，313(2):67-77. DOI：10.1152/ajpregu.00483.2016.
[21]	YADAV A, KATARIA M A, SAINI V，et al. Role of leptin and adiponectin in insulin resistance[J]. Clin Chim Acta，2013，417:80-84. DOI：10.1016/j.cca.2012.12.007.
[22]	ACHARI A E, JAIN S K. Adiponectin，a therapeutic target for obesity，diabetes，and endothelial dysfunction[J]. Int J Mol Sci，2017，18(6):1321. DOI：10.3390/ijms18061321.
[23]	CASELLI C, D'AMICO A, CABIATI M，et al. Back to the heart: the protective role of adiponectin[J]. Pharmacol Res，2014，82:9-20. DOI：10.1016/j.phrs.2014.03.003.
[24]	PADILLA J, VIEIRA-POTTER V J, JIA G H，et al. Role of perivascular adipose tissue on vascular reactive oxygen species in type 2 diabetes: a give-and-take relationship[J]. Diabetes，2015，64(6):1904-1906. DOI：10.2337/db15-0096.
[25]	CANO P, CARDINALI D P, RÍOS-LUGO M J，et al. Effect of a high-fat diet on 24-hour pattern of circulating adipocytokines in rats[J]. Obesity（Silver Spring），2009，17(10):1866-1871. DOI：10.1038/oby.2009.200.
[26]	BOUCHI R, ASAKAWA M, OHARA N，et al. Indirect measure of visceral adiposity 'a Body Shape Index’ （ABSI） is associated with arterial stiffness in patients with type 2 diabetes[J]. BMJ Open Diabetes Res Care，2016，4(1):e000188. DOI：10.1136/bmjdrc-2015-000188.
[27]	LI G, YAO T, WU X W，et al. Novel and traditional anthropometric indices for identifying arterial stiffness in overweight and obese adults[J]. Clin Nutr，2020，39(3):893-900. DOI：10.1016/j.clnu.2019.03.029.
[28]	ATAEE Z, AGHAEE A, SOBHANI S R，et al. Evaluation of arterial stiffness and its relation to innovative anthropometric indices in Persian adults[J]. Int J Hypertens，2023，2023:2180923. DOI：10.1155/2023/2180923.
[29]	DUPONT J J, KENNEY R M, PATEL A R，et al. Sex differences in mechanisms of arterial stiffness[J]. Br J Pharmacol，2019，176(21):4208-4225. DOI：10.1111/bph.14624.
[30]	SCUTERI A, ORRU' M, MORRELL C H，et al. Associations of large artery structure and function with adiposity：effects of age，gender，and hypertension. The SardiNIA Study[J]. Atherosclerosis，2012，221(1):189-197. DOI：10.1016/j.atherosclerosis.2011.11.045.
[31]	ZHANG J, FANG L Z, QIU L F，et al. Comparison of the ability to identify arterial stiffness between two new anthropometric indices and classical obesity indices in Chinese adults[J]. Atherosclerosis，2017，263:263-271. DOI：10.1016/j.atherosclerosis.2017.06.031.
[32]	TANG J M, ZHAO S, YU S K，et al. Association between hypertension-mediated organ damage and obesity defined by novel anthropometric indices in community-dwelling elderly individuals[J]. Clin Nutr，2021，40(6):4473-4480. DOI：10.1016/j.clnu.2020.12.035.
[33]	LAKATTA E G, LEVY D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: part I: aging arteries: a set up for vascular disease[J]. Circulation，2003，107(1):139-146. DOI：10.1161/01.cir.0000048892.83521.58.
[34]	SCHUTTE A E, KRUGER R, GAFANE-MATEMANE L F，et al. Ethnicity and arterial stiffness[J]. Arterioscler Thromb Vasc Biol，2020，40(5):1044-1054. DOI：10.1161/ATVBAHA.120.313133.
[35]	NILSSON P M, BOUTOUYRIE P, CUNHA P，et al. Early vascular ageing in translation: from laboratory investigations to clinical applications in cardiovascular prevention[J]. J Hypertens，2013，31(8):1517-1526. DOI：10.1097/HJH.0b013e328361e4bd.
[36]	OTAKI Y, WATANABE T, KONTA T，et al. A body shape index and aortic disease-related mortality in Japanese general population[J]. J Atheroscler Thromb，2023，30(7):754-766. DOI：10.5551/jat.63753.
[37]	SUGIURA T, DOHI Y, TAKAGI Y，et al. A body shape index could serve to identify individuals with metabolic syndrome and increased arterial stiffness in the middle-aged population[J]. Clin Nutr ESPEN，2021，46:251-258. DOI：10.1016/j.clnesp.2021.10.001.
[38]	NAGAYAMA D, FUJISHIRO K, TSUDA S，et al. Enhanced prediction of renal function decline by replacing waist circumference with "a Body Shape Index （ABSI）" in diagnosing metabolic syndrome: a retrospective cohort study in Japan[J]. Int J Obes（Lond），2022，46(3):564-573. DOI：10.1038/s41366-021-01026-7.
[39]	BAWADI H, ABOUWATFA M, ALSAEED S，et al. Body shape index is a stronger predictor of diabetes[J]. Nutrients，2019，11(5):1018. DOI：10.3390/nu11051018.
[40]	ZHANG Y, GAO W X, LI B Q，et al. The association between a body shape index and elevated urinary albumin-creatinine ratio in Chinese community adults[J]. Front Endocrinol（Lausanne），2022，13:955241. DOI：10.3389/fendo.2022.955241.
[41]	RYU K, SULIMAN M E, QURESHI A R，et al. Central obesity as assessed by conicity index and a-body shape index associates with cardiovascular risk factors and mortality in kidney failure patients[J]. Front Nutr，2023，10:1035343. DOI：10.3389/fnut.2023.1035343.
[42]	NAM K W, KWON H M, JEONG H Y，et al. Association of body shape index with cerebral small vessel disease[J]. Obes Facts，2023，16(2):204-211. DOI：10.1159/000528701.
[43]	LOTFI K, HASSANZADEH KESHTELI A, SANEEI P，et al. A body shape index and body roundness index in relation to anxiety，depression，and psychological distress in adults[J]. Front Nutr，2022，9:843155. DOI：10.3389/fnut.2022.843155.
[44]	GE W X, YI L P, XIAO C Q，et al. Effectiveness of a body shape index in predicting pediatric high blood pressure[J]. Pediatr Res，2022，92(3):871-879. DOI：10.1038/s41390-021-01844-5.
[45]	KUANG M B, SHENG G T, HU C，et al. The value of combining the simple anthropometric obesity parameters，Body Mass Index （BMI） and a Body Shape Index （ABSI），to assess the risk of non-alcoholic fatty liver disease[J]. Lipids Health Dis，2022，21(1):104. DOI：10.1186/s12944-022-01717-8.